IMR Press / EJGO / Volume 6 / Issue 3 / pii/1985044

European Journal of Gynaecological Oncology (EJGO) is published by IMR Press from Volume 40 Issue 1 (2019). Previous articles were published by another publisher on a subscription basis, and they are hosted by IMR Press on imrpress.com as a courtesy and upon agreement with S.O.G.

Original Research

Combined treatment in adenocarcinoma of cervix

Show Less
1 Department of Obstetrics and Gynaecology, University of Hong Kong, Queen Mary Hospital, Hong Kong
2 Department of Pathology, University of Hong Kong, Queen Mary Hospital, Hong Kong
3 Institute of Radiotherapy, Queen Mary Hospital, Hong Kong
4 Department of Obstetrics and Gynaecology, University of Hong Kong, Queen Mary Hospital, Hong Kong
Eur. J. Gynaecol. Oncol. 1985, 6(3), 186–192;
Published: 10 October 1985
Abstract

From January 1976 - end of 1979, 427 patients with cervical cancer were treated in the Department of Gynaecology, University of Hong Kong. Twenty-seven (6%) had primary ade­nocarcinoma of cervix. Eighteen patients with Stage I and eady Stage II were treated by preope­rative irradiation and Wertheim hysterectomy. Serial cervical biopsies were taken to assess the re­sponse to radiotherapy. All the cervical biopsies as well as the surgical specimens were read by the same pathologist. 83% showed residual dividing tumour cells in the surgical specimens. One hundred and forty-five-patients with early squamous cervical cancer were similarly treated during the same pe­riod; only 13% had residual tumour in the specimens (x2 test p < 0.001). All the patients are being followed up regularly. Fifteen patients with early cervical adenocarcinoma are free from disease. The shortest period of follow-up is 5 1/4 years.

Keywords
Adenocarcinoma
Cervix
Share
Back to top